Yazhuo Du

1PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 30, 2026
HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering.

Jiliang Zhao, Dongping Zhang, Yun-Yueh Lu

Pageof 1

Frequent Collaborators

1 joint publications

Sihe Zhang

1 joint publications

Kunkun Ge

1 joint publications

Song Xu

1 joint publications

Hongkai Zhang